Application
Western blot analysis of BPIL2 Antibody (N-term) in A2058, A375 cell line lysates (35ug/lane). BPIL2 (arrow) was detected using the purified Pab.Application
Formalin-fixed and paraffin-embedded human skin psoriasis with BPIL2 Antibody (N-term), which was peroxidase-conjugated to the secondary antibody, followed by DAB staining. This data demonstrates the use of this antibody for immunohistochemistry; clinical relevance has not been evaluated.| Product Name | BPIL2 Antibody (N-term) |
|---|---|
| Antibody Type | Primary Antibodies |
| Antigen Alias | BPIFC; BPIL2; BPI fold-containing family C protein; Bactericidal/permeability-increasing protein-like 2 |
| Clonality | Polyclonal |
|---|---|
| Isotype | Ig |
| Host Species | Rabbit |
| Tested Applications | WBIHC |
| WB:1:50~100 IHC |
|
| Species Reactivity | Human |
| Concentration | 1mg/ml |
| Gene Synonyms | BPIL2 |
|---|---|
| Alternative Names | BPIFC BPIL2 BPI fold-containing family C protein Bactericidal/permeability-increasing protein-like 2 |
| Molecular Weight(MW) | 56469 Da |
| Tissue Specificity | Detected in the basal layer of the epidermis from inflammatory skin from psoriasis patients, but not in normal skin |
| Cellular Localization | Secreted (By similarity). |
| Entrez Gene | 254240 |
|---|
Application
Western blot analysis of BPIL2 Antibody (N-term) in A2058, A375 cell line lysates (35ug/lane). BPIL2 (arrow) was detected using the purified Pab.
Application
Formalin-fixed and paraffin-embedded human skin psoriasis with BPIL2 Antibody (N-term), which was peroxidase-conjugated to the secondary antibody, followed by DAB staining. This data demonstrates the use of this antibody for immunohistochemistry; clinical relevance has not been evaluated.| Application Notes | WB:1:50~100 IHC |
|---|
| Form | Liquid |
|---|---|
| Storage Instructions | For short-term storage, store at 4° C. For long-term storage, aliquot and store at -20ºC or below. Avoid multiple freeze-thaw cycles. |
| Storage Buffer | Purified polyclonal antibody supplied in PBS with 0.09% (W/V) sodium azide. This antibody is prepared by Saturated Ammonium Sulfate (SAS) precipitation followed by dialysis against PBS. |
